120 related articles for article (PubMed ID: 17847605)
1. Pediatric research posing a minor increase over minimal risk and no prospect of direct benefit: challenging 45 CFR 46.406.
Iltis A
Account Res; 2007; 14(1):19-34. PubMed ID: 17847605
[TBL] [Abstract][Full Text] [Related]
2. Phase I research and the meaning of direct benefit.
Ross L
J Pediatr; 2006 Jul; 149(1 Suppl):S20-4. PubMed ID: 16829237
[TBL] [Abstract][Full Text] [Related]
3. Determining risk in pediatric research with no prospect of direct benefit: time for a national consensus on the interpretation of federal regulations.
Fisher CB; Kornetsky SZ; Prentice ED
Am J Bioeth; 2007 Mar; 7(3):5-10. PubMed ID: 17366219
[TBL] [Abstract][Full Text] [Related]
4. How do institutional review boards apply the federal risk and benefit standards for pediatric research?
Shah S; Whittle A; Wilfond B; Gensler G; Wendler D
JAMA; 2004 Jan; 291(4):476-82. PubMed ID: 14747505
[TBL] [Abstract][Full Text] [Related]
5. Ethical challenges in neonatal research: Summary report of the ethics group of the newborn drug development initiative.
Baer GR; Nelson RM;
Clin Ther; 2006 Sep; 28(9):1399-407. PubMed ID: 17062312
[TBL] [Abstract][Full Text] [Related]
6. Minimal risk in pediatric research as a function of age.
Wendler D
Arch Pediatr Adolesc Med; 2009 Feb; 163(2):115-8. PubMed ID: 19188642
[TBL] [Abstract][Full Text] [Related]
7. Acceptable risks and burdens for children in research without direct benefit: a systematic analysis of the decisions made by the Dutch Central Committee.
Westra AE; Sukhai RN; Wit JM; de Beaufort ID; Cohen AF
J Med Ethics; 2010 Jul; 36(7):420-4. PubMed ID: 20605997
[TBL] [Abstract][Full Text] [Related]
8. Family pediatrics: report of the Task Force on the Family.
Schor EL;
Pediatrics; 2003 Jun; 111(6 Pt 2):1541-71. PubMed ID: 12777595
[TBL] [Abstract][Full Text] [Related]
9. Ethical considerations about observational research in children.
Wilfond B
J Trauma; 2007 Dec; 63(6 Suppl):S146-51; discussion S152-4. PubMed ID: 18091208
[TBL] [Abstract][Full Text] [Related]
10. Quantifying the federal minimal risk standard: implications for pediatric research without a prospect of direct benefit.
Wendler D; Belsky L; Thompson KM; Emanuel EJ
JAMA; 2005 Aug; 294(7):826-32. PubMed ID: 16106008
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic stem cell transplant research with pediatric donors: when can institutional review boards approve it?
Peerzada JM; Wendler D
Transplantation; 2006 Jun; 81(12):1616-20. PubMed ID: 16794524
[TBL] [Abstract][Full Text] [Related]
12. Characterizing the level of risk in pediatric research: an ethical examination of the federal regulations.
Dyson M; Parsi K
J Clin Ethics; 2010; 21(3):212-20. PubMed ID: 21089990
[TBL] [Abstract][Full Text] [Related]
13. Improving balance in regulatory oversight of research in children and adolescents: a clinical investigator's perspective.
Rosenfield RL
Ann N Y Acad Sci; 2008; 1135():287-95. PubMed ID: 18574235
[TBL] [Abstract][Full Text] [Related]
14. Children's and their parents' views on facing research risks for the benefit of others.
Wendler D; Jenkins T
Arch Pediatr Adolesc Med; 2008 Jan; 162(1):9-14. PubMed ID: 18180406
[TBL] [Abstract][Full Text] [Related]
15. The legal ethics of pediatric research.
Coleman DL
Duke Law J; 2007 Dec; 57(3):517-624. PubMed ID: 18354870
[TBL] [Abstract][Full Text] [Related]
16. Dental screening and referral of young children by pediatric primary care providers.
dela Cruz GG; Rozier RG; Slade G
Pediatrics; 2004 Nov; 114(5):e642-52. PubMed ID: 15520094
[TBL] [Abstract][Full Text] [Related]
17. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
18. Central ethical dilemmas in research involving children.
Tauer CA
Account Res; 2002; 9(3-4):127-42. PubMed ID: 12816123
[TBL] [Abstract][Full Text] [Related]
19. [Medical research in children: should the rules be eased?].
Westra AE
Ned Tijdschr Geneeskd; 2010; 154():A2275. PubMed ID: 20858299
[TBL] [Abstract][Full Text] [Related]
20. Moral responsibility to attain thorough pediatric drug labeling.
Waisel DB
Paediatr Anaesth; 2009 Oct; 19(10):989-93. PubMed ID: 19659675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
